688319 Chengdu Olymvax Biopharmaceuticals Inc

Watchlist

10.99
-0.01-0.09%

Market Closed Dec 27 15:00 CST

4.46BMarket Cap-523.33P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc Key Stats

According to the latest financial report of Chengdu Olymvax Biopharmaceuticals Inc, the latest earnings per share (TTM) for the company is 0.01. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

BVPS

Analyzing a company's fundamentals? Check out Chengdu Olymvax Biopharmaceuticals Inc's latest financial report to see how much their book value per share (BVPS) is currently at 2.24.

Currency: CNY

Cumulative Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Chengdu Olymvax Biopharmaceuticals Inc shows that the company's current ratio is 1.86, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Chengdu Olymvax Biopharmaceuticals Inc, the quick ratio is 1.67, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

ROE

Want to learn more about the financial health of Chengdu Olymvax Biopharmaceuticals Inc? The latest ROE figure is 0.44%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Chengdu Olymvax Biopharmaceuticals Inc, the total asset return on investment (ROA) is -0.01%.

Currency: CNY

Cumulative Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Chengdu Olymvax Biopharmaceuticals Inc's latest financial report to see how their gross margin is doing - currently at 94.72%.

Currency: CNY

Cumulative Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Chengdu Olymvax Biopharmaceuticals Inc, the net profit margin is -0.02%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Top CN Stock Gainers

Symbol Price % Chg

Suzhou Industrial Park Heshun Electric

300141

11.14 +20.04%

Guangdong Xiongsu Technology Group

300599

7.67 +20.03%

Sichuan Chuanhuan Technology

300547

24.41 +20.01%

Shanghai Wisdom Information Technology